These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8769076)

  • 1. [The effect of amphoteric tensides on the pharmaceutic availability of model drugs according to formulation].
    Bialik W; Kuferska E; Jaworski E
    Acta Pol Pharm; 1992; 49(1-2):21-3. PubMed ID: 8769076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of pharmaceutical availability of salicylic acid from tablets containing amphoteric surfactants.
    Bialik W; Jaworski E
    Pharmazie; 1990 May; 45(5):376-7. PubMed ID: 2395904
    [No Abstract]   [Full Text] [Related]  

  • 3. The influence of salicylic acid on the in vitro release of anthralin from an o/w cream.
    Kneczke M; Rahm C; Landersjö L
    Acta Pharm Nord; 1990; 2(5):313-8. PubMed ID: 2083035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the release of drugs from O/W emulsion ointments using the mathematical interpretations. Part 2: Influence of the ointment composition.
    Bialik W
    Pharmazie; 1985 Sep; 40(9):637-9. PubMed ID: 4070346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and bioavailability assessment of ramipril nanoemulsion formulation.
    Shafiq S; Shakeel F; Talegaonkar S; Ahmad FJ; Khar RK; Ali M
    Eur J Pharm Biopharm; 2007 May; 66(2):227-43. PubMed ID: 17127045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the release of drugs from O/W emulsion ointments using mathematical interpretations. Part 4: Kinetic analysis of drug release from thick layers.
    Bialik W
    Pharmazie; 1990 Feb; 45(2):119-20. PubMed ID: 2339166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A new mathematical model for the in vitro release of drugs from o/w emulsion ointments. II. Experimental part].
    Bialik W
    Acta Pol Pharm; 1985; 42(1):74-8. PubMed ID: 4013801
    [No Abstract]   [Full Text] [Related]  

  • 8. [Examination of the properties of amphotensides with potential use as pharmaceuticals].
    Bialik W
    Acta Pol Pharm; 1992; 49(1-2):97-101. PubMed ID: 8769083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Release insoluble drugs from the hydrophobic tablet matrix. 2. Influence of non-ionogenic surface-active substances].
    Schekerdjiski R; Minkov E; Mihailova D; Trandafilov T
    Pharmazie; 1971 Oct; 26(10):635-6. PubMed ID: 5149135
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the release of drugs from O/W emulsion ointments using the mathematical interpretations. Part 3: Kinetic approach.
    Bialik W
    Pharmazie; 1987 May; 42(5):317-20. PubMed ID: 3671442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR; Choi YW; Cui JH; Lee BJ
    J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An enteric-coated dry emulsion formulation for oral insulin delivery.
    Toorisaka E; Hashida M; Kamiya N; Ono H; Kokazu Y; Goto M
    J Control Release; 2005 Sep; 107(1):91-6. PubMed ID: 16039746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the release of solubilized drugs from ointment bases. Part 8: The effect of emulsifiers on pharmaceutical availability of ethanolamine, diethanolamine and morpholine from emulsive ointments.
    Kubis A; Jadach W; Małecka K
    Pharmazie; 1984 Mar; 39(3):168-70. PubMed ID: 6728889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pickering w/o emulsions: drug release and topical delivery.
    Frelichowska J; Bolzinger MA; Valour JP; Mouaziz H; Pelletier J; Chevalier Y
    Int J Pharm; 2009 Feb; 368(1-2):7-15. PubMed ID: 18992799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro studies on the application of colloidal emulsion aphrons to drug overdose treatment.
    Dai Y; Deng T; Lu F
    Int J Pharm; 2006 Mar; 311(1-2):165-71. PubMed ID: 16439075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Stability and new formulations of hexetidine. 2. Formulations and in vitro bioavailability].
    Schmidt PC; Kaupp H
    Pharmazie; 1993 Nov; 48(11):837-41. PubMed ID: 8295912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Concentration of free tenside in the water phase of unguentum emulsificans aquosum DAB 7 DDR and its solubilization effect on drugs].
    Horsch W; Kögel J; Teich C; Wendrich M
    Pharmazie; 1972 Sep; 27(9):614. PubMed ID: 5086364
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of cationic surfactant on transport of surface-active and non-surface-active model drugs and emulsion stability in triphasic systems.
    Chidambaram N; Burgess DJ
    AAPS PharmSci; 2000; 2(3):E28. PubMed ID: 11741244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Release characteristics of anionic drug compounds from liquid crystalline gels. Part II. The effects of ion pairing and buffering on the passive delivery of anionic drugs across non-rate-limiting membranes.
    Fitzpatrick D; Corish J
    Int J Pharm; 2006 Mar; 311(1-2):139-46. PubMed ID: 16426777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel farnesylthiosalicylate (FTS)-eluting composite structures.
    Kraitzer A; Kloog Y; Zilberman M
    Eur J Pharm Sci; 2009 Jun; 37(3-4):351-62. PubMed ID: 19491026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.